Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tingting Lei

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Cell|June 20, 2020
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing AntibodiesAhmed O Hassan, James Brett Case, Emma S Winkler, et al.
Nature|February 15, 2022
Germinal centre-driven maturation of B cell response to mRNA vaccinationWooseob Kim, Julian Q Zhou, Stephen C Horvath, et al.
Nature|June 28, 2021
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responsesJackson S Turner, Jane A O'Halloran, Elizaveta Kalaidina, et al.
Nature|September 1, 2020
Human germinal centres engage memory and naive B cells after influenza vaccinationJackson S Turner, Julian Q Zhou, Julianna Han, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2020
A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 InfectionWafaa B Alsoussi, Jackson S Turner, James B Case, et al.
Clinical Chemistry|November 25, 2003
Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirusJingqiang Wang, Jie Wen, Jingxiang Li, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variantsAaron J Schmitz, Jackson S Turner, Zhuoming Liu, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infectionLina Ma, Sanjaya K Sahu, Marlene Cano, et al.
Cell|January 13, 2022
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humansPhilip A Mudd, Anastasia A Minervina, Mikhail V Pogorelyy, et al.
Immunity|August 31, 2021
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variantsAaron J Schmitz, Jackson S Turner, Zhuoming Liu, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Cell|June 20, 2020
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing AntibodiesAhmed O Hassan, James Brett Case, Emma S Winkler, et al.
Nature|February 15, 2022
Germinal centre-driven maturation of B cell response to mRNA vaccinationWooseob Kim, Julian Q Zhou, Stephen C Horvath, et al.
Nature|June 28, 2021
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responsesJackson S Turner, Jane A O'Halloran, Elizaveta Kalaidina, et al.
Nature|September 1, 2020
Human germinal centres engage memory and naive B cells after influenza vaccinationJackson S Turner, Julian Q Zhou, Julianna Han, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2020
A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 InfectionWafaa B Alsoussi, Jackson S Turner, James B Case, et al.
Clinical Chemistry|November 25, 2003
Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirusJingqiang Wang, Jie Wen, Jingxiang Li, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variantsAaron J Schmitz, Jackson S Turner, Zhuoming Liu, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infectionLina Ma, Sanjaya K Sahu, Marlene Cano, et al.
Cell|January 13, 2022
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humansPhilip A Mudd, Anastasia A Minervina, Mikhail V Pogorelyy, et al.
Immunity|August 31, 2021
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variantsAaron J Schmitz, Jackson S Turner, Zhuoming Liu, et al.
Pageof 8